SCHEMBL7513361

SCHEMBL7513361

NS(=O)(=O)c1ccc(-c2oc(Cc3ccccc3)nc2-c2ccccc2Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 4/20 0.53
▸ RXRA P19793 2/20 0.53
▸ RXRB P28702 2/20 0.53
▸ CA1 P00915 6/20 0.51
▸ CA2 P00918 6/20 0.51
▸ CA12 O43570 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ PTGS2 P35354 8/20 0.46
▸ PTGS1 P23219 5/20 0.46
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7500825 0.91 NR4A2 (0.55) NR4A2RXRARXRBCA1CA2
SCHEMBL7511507 0.91 CA1 (0.44) NR4A2RXRARXRBCA1CA2
SCHEMBL7505854 0.89 RXRA (0.46) NR4A2RXRARXRBCA1CA2
SCHEMBL7504953 0.89 CA2 (0.44) NR4A2RXRARXRBCA1CA2
SCHEMBL7502817 0.89 CA1 (0.48) NR4A2RXRARXRBCA1CA2
SCHEMBL7508430 0.88 CA2 (0.42) NR4A2RXRARXRBCA1CA2
SCHEMBL7500284 0.88 CA1 (0.43) NR4A2RXRARXRBCA1CA2
SCHEMBL7504983 0.87 RXRA (0.53) NR4A2RXRARXRBCA1CA2
SCHEMBL7513276 0.87 CA1 (0.48) CA1CA2CA12CA9CA14
SCHEMBL7504153 0.86 RXRA (0.53) NR4A2RXRARXRBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
Send feedback